{"schema_version":"secwatch.filing_event.v1","accession":"0001764046-26-000090","form_type":"8-K","ticker":"CLVT","cik":"0001764046","company_name":"CLARIVATE PLC","filed_at":"2026-07-29T10:03:16+00:00","discovered_at":"2026-07-29T10:10:00.253048+00:00","generated_at":"2026-07-29T10:10:30.462294+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Clarivate Q2 revenue down 5.5% to $587M; net loss $269M on goodwill impairment; reaffirms FY outlook","bullets":["Q2 total revenues $587.3M, down 5.5% YoY; organic revenue -1.5% as subscription +0.7% offset by transactional -15.7%.","Net loss $268.6M ($0.42 diluted EPS) vs $72.0M loss in Q2 2025, driven by $221.7M non-cash goodwill impairment.","Adjusted net income $123.1M ($0.19 diluted EPS) vs $123.3M ($0.18) in Q2 2025; adjusted EBITDA $247.2M vs $261.6M.","First-half 2026 free cash flow $122.9M vs $160.6M prior year; debt reduced by $218.4M including $100M accelerated repayment.","Reaffirms full-year 2026 outlook; previously announced Life Sciences & Healthcare segment divestiture ongoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001764046-26-000090","json":"https://secwatch.observer/filing/0001764046-26-000090.json","markdown":"https://secwatch.observer/filing/0001764046-26-000090.md","text":"https://secwatch.observer/filing/0001764046-26-000090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000090/0001764046-26-000090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1764046/000176404626000090/clvt-20260729.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-29T10:10:30.462294+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}